JP2006515316A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006515316A5 JP2006515316A5 JP2005500296A JP2005500296A JP2006515316A5 JP 2006515316 A5 JP2006515316 A5 JP 2006515316A5 JP 2005500296 A JP2005500296 A JP 2005500296A JP 2005500296 A JP2005500296 A JP 2005500296A JP 2006515316 A5 JP2006515316 A5 JP 2006515316A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- compound
- propyl
- pyrazol
- dione
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *c1nc(N(*)C(N(*)C2=O)=O)c2[n]1* Chemical compound *c1nc(N(*)C(N(*)C2=O)=O)c2[n]1* 0.000 description 2
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2003/014085 WO2004106337A1 (en) | 2003-05-06 | 2003-05-06 | Xanthine derivatives as a2b adenosine receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006515316A JP2006515316A (ja) | 2006-05-25 |
| JP2006515316A5 true JP2006515316A5 (enExample) | 2006-07-06 |
Family
ID=33488737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005500296A Pending JP2006515316A (ja) | 2003-05-06 | 2003-05-06 | Ａ２ｂアデノシンレセプターアンタゴニストであるキサンチン誘導体 |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1622908B1 (enExample) |
| JP (1) | JP2006515316A (enExample) |
| CN (1) | CN100590125C (enExample) |
| AT (1) | ATE403656T1 (enExample) |
| AU (1) | AU2003249604B2 (enExample) |
| CA (1) | CA2524778C (enExample) |
| CY (1) | CY1108457T1 (enExample) |
| DE (1) | DE60322748D1 (enExample) |
| DK (1) | DK1622908T3 (enExample) |
| ES (1) | ES2311759T3 (enExample) |
| MX (1) | MXPA05011860A (enExample) |
| NZ (1) | NZ543416A (enExample) |
| PT (1) | PT1622908E (enExample) |
| SI (1) | SI1622908T1 (enExample) |
| WO (1) | WO2004106337A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2007015909A (es) * | 2005-06-16 | 2008-03-06 | Cv Therapeutics Inc | Profarmacos de antagonistas del receptor de adenosina a2b. |
| ES2270715B1 (es) | 2005-07-29 | 2008-04-01 | Laboratorios Almirall S.A. | Nuevos derivados de pirazina. |
| ES2274712B1 (es) | 2005-10-06 | 2008-03-01 | Laboratorios Almirall S.A. | Nuevos derivados imidazopiridina. |
| WO2007103776A2 (en) * | 2006-03-02 | 2007-09-13 | Cv Therapeutics, Inc. | A2a adenosine receptor antagonists |
| WO2009088518A1 (en) * | 2008-01-11 | 2009-07-16 | Cv Therapeutics, Inc. | A2b adenosine receptor antagonists for the treatment of cancer |
| US8871751B2 (en) | 2008-01-18 | 2014-10-28 | The Board Of Trustees Of The University Of Illinois | Compositions and methods relating to nuclear hormone and steroid hormone receptors including inhibitors of estrogen receptor alpha-mediated gene expression and inhibition of breast cancer |
| EP2268641B1 (en) | 2008-03-26 | 2014-09-03 | Advinus Therapeutics Pvt. Ltd. | Heterocyclic compounds as adenosine receptor antagonist |
| WO2009157938A1 (en) * | 2008-06-26 | 2009-12-30 | Cv Therapeutics, Inc. | A2b adenosine receptor antagonists for treating cancer |
| WO2010103547A2 (en) | 2009-03-13 | 2010-09-16 | Advinus Therapeutics Private Limited | Substituted fused pyrimidine compounds |
| EP2499142B1 (en) | 2009-11-09 | 2016-09-21 | Advinus Therapeutics Limited | Substituted fused pyrimidine compounds, its preparation and uses thereof |
| CN103261200B (zh) * | 2010-09-13 | 2016-03-30 | 阿迪维纳斯疗法有限公司 | 作为a2b腺苷受体拮抗剂的前药的嘌呤化合物、它们的制备方法及医药用途 |
| WO2014143799A2 (en) * | 2013-03-15 | 2014-09-18 | Hydra Biosciences, Inc. | Substituted xanthines and methods of use thereof |
| ES2580702B1 (es) | 2015-02-25 | 2017-06-08 | Palobiofarma, S.L. | Derivados de 2-aminopiridina como antagonistas del receptor A2b de adenosina y ligandos del receptor MT3 de melatonina |
| EP3389664A4 (en) | 2015-12-14 | 2020-01-08 | Raze Therapeutics Inc. | MTHFD2 CAFFEIN INHIBITORS AND USES THEREOF |
| WO2018204661A1 (en) * | 2017-05-05 | 2018-11-08 | Arcus Biosciences, Inc. | Quinazoline-pyridine derivatives for the treatment of cancer-related disorders |
| EP3762386B1 (en) * | 2018-03-05 | 2024-01-24 | Teon Therapeutics, Inc. | Adenosine receptor antagonists and uses thereof |
| SG11202106963YA (en) | 2019-01-11 | 2021-07-29 | Omeros Corp | Methods and compositions for treating cancer |
| CN118459463B (zh) * | 2024-07-10 | 2024-09-06 | 山东中医药大学附属医院 | 一种化合物及其制备方法和治疗2型糖尿病的用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8510758D0 (en) * | 1985-04-27 | 1985-06-05 | Wellcome Found | Compounds |
| US4878296A (en) * | 1988-04-22 | 1989-11-07 | The United States Of America As Represented By The Secretary Of The Navy | Apparatus and method for locating the axis of symmetry (center of circular cross section) of three dimensional objects |
| DE3843117A1 (de) * | 1988-12-22 | 1990-06-28 | Boehringer Ingelheim Kg | Neue xanthinderivate mit adenosin-antagonistischer wirkung |
| JPH06102662B2 (ja) * | 1989-09-01 | 1994-12-14 | 協和醗酵工業株式会社 | キサンチン誘導体 |
| WO1995011681A1 (en) * | 1993-10-29 | 1995-05-04 | Merck & Co., Inc. | Human adenosine receptor antagonists |
| DE19535504A1 (de) * | 1995-09-25 | 1997-03-27 | Bayer Ag | Substituierte Xanthine |
| US6117878A (en) * | 1998-02-24 | 2000-09-12 | University Of Virginia | 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors |
| EP0956855B1 (en) * | 1998-04-24 | 2003-03-12 | K.U. Leuven Research & Development | Immunosuppressive effects of 8 substituted xanthine derivatives |
| US6545002B1 (en) * | 1999-06-01 | 2003-04-08 | University Of Virginia Patent Foundation | Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors |
| KR100883292B1 (ko) * | 2001-06-29 | 2009-02-11 | 씨브이 쎄러퓨틱스, 인코포레이티드 | Ａ２ｂ 아데노신 수용체 길항제로서의 퓨린 유도체 |
| CN100467469C (zh) * | 2001-11-09 | 2009-03-11 | Cv医药有限公司 | A2b腺苷受体拮抗剂 |
| CA2443023A1 (en) * | 2002-02-01 | 2003-08-07 | King Pharmaceuticals Research And Development, Inc. | 8-heteroaryl xanthine adenosine a2b receptor antagonists |
-
2003
- 2003-05-06 PT PT03817096T patent/PT1622908E/pt unknown
- 2003-05-06 SI SI200331355T patent/SI1622908T1/sl unknown
- 2003-05-06 WO PCT/US2003/014085 patent/WO2004106337A1/en not_active Ceased
- 2003-05-06 JP JP2005500296A patent/JP2006515316A/ja active Pending
- 2003-05-06 AU AU2003249604A patent/AU2003249604B2/en not_active Ceased
- 2003-05-06 DK DK03817096T patent/DK1622908T3/da active
- 2003-05-06 ES ES03817096T patent/ES2311759T3/es not_active Expired - Lifetime
- 2003-05-06 DE DE60322748T patent/DE60322748D1/de not_active Expired - Lifetime
- 2003-05-06 MX MXPA05011860A patent/MXPA05011860A/es active IP Right Grant
- 2003-05-06 AT AT03817096T patent/ATE403656T1/de active
- 2003-05-06 NZ NZ543416A patent/NZ543416A/en not_active IP Right Cessation
- 2003-05-06 EP EP03817096A patent/EP1622908B1/en not_active Expired - Lifetime
- 2003-05-06 CA CA2524778A patent/CA2524778C/en not_active Expired - Fee Related
- 2003-05-06 CN CN03826411A patent/CN100590125C/zh not_active Expired - Fee Related
-
2008
- 2008-10-27 CY CY20081101212T patent/CY1108457T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006515316A5 (enExample) | ||
| US11034685B2 (en) | Aminopyridine derivatives as TAM family kinase inhibitors | |
| JP2005509036A5 (enExample) | ||
| JP4672820B2 (ja) | ＧＡＢＡα５リガンドとしての置換１，２，４−トリアゾロ［３，４−ａ］フタラジン誘導体 | |
| US10364256B2 (en) | Biaryl pyrazoles as NRF2 regulators | |
| CA2466477A1 (en) | A2b adenosine receptor antagonists | |
| JP2012513958A (ja) | １，２，４−オキサジアゾール誘導体およびそれらの治療的使用 | |
| EP2375904B1 (en) | Biaryl carboxamides | |
| EP1501808B1 (en) | Tachykinin receptor antagonists | |
| TWI808305B (zh) | 作為法尼醇x受體調節劑之經取代雙環化合物 | |
| RU2007117907A (ru) | Способ предупреждения и лечения ремоделирования дыхательных путей и воспаления легких с применением антагонистов аденозиновых рецепторов a2b | |
| JP2014525444A5 (enExample) | ||
| JP2018534328A5 (enExample) | ||
| JP2014518214A5 (enExample) | ||
| BR112019017171A2 (pt) | compostos 1h-pirazolo[4,3-b]piridinas inibidores de pde1, composição farmacêutica e uso dos mesmos | |
| JPWO2007007910A1 (ja) | ヘテロ環置換ベンズイミダゾール誘導体 | |
| US8399451B2 (en) | Heterocyclic compounds | |
| JP2007509947A5 (enExample) | ||
| JP2013514308A5 (enExample) | ||
| JP2018527325A5 (enExample) | ||
| JP2008511654A5 (enExample) | ||
| RU2007107605A (ru) | Способ заживления ран с применением антагонистов аденозинового рецептора a2b | |
| RU2005134232A (ru) | Производные ксантина в качестве антагонистов а2в аденозинового рецептора | |
| JP2007526284A5 (enExample) |